TNFSF9 Antikörper
Kurzübersicht für TNFSF9 Antikörper (ABIN2192994)
Target
Alle TNFSF9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- 4-1BB Ligand (TNFSF9, CD137, CDw137, ILA, MGC2172, T-cell, 4-1BB homolog, T-cell antigen ILA, Tumor necrosis factor receptor superfamily member 9 precursor)
-
Aufreinigung
- Purified by Protein G affinity chromatography.
-
Immunogen
- Recombinant human 4-1BB Ligand extracellular domain.
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with 40-50 % glycerol, PBS.
-
Buffer
- Supplied as a lyophilized powder in 0.2 um filtered solution in PBS with 5 % trehalose.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- TNFSF9 (Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9))
-
Andere Bezeichnung
- 4-1BB Ligand
-
Pathways
- Activated T Cell Proliferation, Cancer Immune Checkpoints
Target
-